Cover Image
Market Research Report

Global Cell Therapy Instrument Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025

Published by Value Market Research Product code 916366
Published Content info 106 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Cell Therapy Instrument Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025
Published: November 1, 2019 Content info: 106 Pages
Description

The report on global Cell Therapy Instrument market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

  • Drivers
  • Increase in count of cancer cell-based therapy clinical trials
  • Promotion cell-based research from government and private organizations
  • Restraints
  • High cost of cell-based research

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Till: 2025

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on product, application, cell type and end-user. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Product:

  • Consumables
  • Equipment
  • Software

By Application:

  • Cell Processing
  • Cell Preservation Distribution & Handling
  • Process Monitoring & Quality Control

By Cell Type:

  • Human Cells
  • Animal Cells

By End-User:

  • Life Science Companies
  • Research Institutes

By Geography:

  • North America (NA) - US & Rest of North America
  • Europe (EU) - UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
  • Latin America (LA) - Brazil & Rest of Latin America
  • Middle East & Africa (MEA) - Middle East and Africa
Table of Contents

Table of Contents

1 PREFACE

  • 1.1. REPORT DESCRIPTION
    • 1.1.1. OBJECTIVE
    • 1.1.2. TARGET AUDIENCE
    • 1.1.3. UNIQUE SELLING PROPOSITION (USP) & OFFERINGS
  • 1.2. RESEARCH SCOPE
  • 1.3. RESEARCH METHODOLOGY
    • 1.3.1. MARKET RESEARCH PROCESS
    • 1.3.2. MARKET RESEARCH METHODOLOGY
      • 1.3.2.1. SECONDARY RESEARCH
      • 1.3.2.2. PRIMARY RESEARCH
      • 1.3.2.3. MODELS

2 EXECUTIVE SUMMARY

  • 2.1. MARKET HIGHLIGHTS
  • 2.2. GLOBAL CELL THERAPY INSTRUMENT MARKET: SNAPSHOT

3 CELL THERAPY INSTRUMENT - INDUSTRY ANALYSIS

  • 3.1. INTRODUCTION
  • 3.2. MARKET DRIVERS
    • 3.2.1. DRIVER 1
    • 3.2.2. DRIVER 2
  • 3.3. MARKET RESTRAINTS
    • 3.3.1. RESTRAINT 1
    • 3.3.2. RESTRAINT 2
  • 3.4. OPPORTUNITIES
    • 3.4.1. OPPORTUNITY 1
  • 3.5. TRENDS
    • 3.5.1. TREND 1
    • 3.5.2. TREND 2
  • 3.6. PORTER'S FIVE FORCE ANALYSIS
  • 3.7. CELL THERAPY INSTRUMENT: MARKET ATTRACTIVENESS ANALYSIS
    • 3.7.1. MARKET ATTRACTIVE ANALYSIS BY PRODUCT
    • 3.7.2. MARKET ATTRACTIVE ANALYSIS BY APPLICATION
    • 3.7.3. MARKET ATTRACTIVE ANALYSIS BY CELL TYPE
    • 3.7.4. MARKET ATTRACTIVE ANALYSIS BY REGION

4 VALUE CHAIN ANALYSIS

  • 4.1. CELL THERAPY INSTRUMENT: VALUE CHAIN ANALYSIS
  • 4.2. CELL THERAPY INSTRUMENT RAW MATERIAL ANALYSIS
    • 4.2.1. LIST OF RAW MATERIALS
    • 4.2.2. CELL THERAPY INSTRUMENT RAW MATERIAL MANUFACTURES LIST
    • 4.2.3. PRICE TREND OF CELL THERAPY INSTRUMENT KEY RAW MATERIALS
  • 4.3. LIST OF POTENTIAL BUYERS
  • 4.4. MARKETING CHANNEL
    • 4.4.1. DIRECT MARKETING
    • 4.4.2. INDIRECT MARKETING
    • 4.4.3. MARKETING CHANNEL DEVELOPMENT TREND

5 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY PRODUCT

  • 5.1. OVERVIEW BY PRODUCT
  • 5.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY PRODUCT
  • 5.3. CONSUMABLES
    • 5.3.1. OVERVIEW
  • 5.4. EQUIPMENT
    • 5.4.1. OVERVIEW
  • 5.5. SOFTWARE
    • 5.5.1. OVERVIEW

6 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY APPLICATION

  • 6.1. OVERVIEW BY APPLICATION
  • 6.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY APPLICATION
  • 6.3. CELL PROCESSING
    • 6.3.1. OVERVIEW
  • 6.4. CELL PRESERVATION DISTRIBUTION & HANDLING
    • 6.4.1. OVERVIEW
  • 6.5. PROCESS MONITORING & QUALITY CONTROL
    • 6.5.1. OVERVIEW

7 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY CELL TYPE

  • 7.1. OVERVIEW BY CELL TYPE
  • 7.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY CELL TYPE
  • 7.3. HUMAN CELLS
    • 7.3.1. OVERVIEW
  • 7.4. ANIMAL CELLS
    • 7.4.1. OVERVIEW

8 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY END-USER

  • 8.1. OVERVIEW BY END-USER
  • 8.2. GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY END-USER
  • 8.3. LIFE SCIENCE COMPANIES
    • 8.3.1. OVERVIEW
  • 8.4. RESEARCH INSTITUTES
    • 8.4.1. OVERVIEW

9 GLOBAL CELL THERAPY INSTRUMENT MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. REGIONAL OUTLOOK
  • 9.2. INTRODUCTION
  • 9.3. NORTH AMERICA
    • 9.3.1. OVERVIEW
    • 9.3.2. NORTH AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.3.3. NORTH AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.3.4. UNITED STATE
    • 9.3.5. REST OF NORTH AMERICA
  • 9.4. EUROPE
    • 9.4.1. OVERVIEW
    • 9.4.2. EUROPE CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.4.3. EUROPE CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.4.4. UNITED KINGDOM
    • 9.4.5. FRANCE
    • 9.4.6. GERMANY
    • 9.4.7. REST OF EUROPE
  • 9.5. ASIA PACIFIC
    • 9.5.1. OVERVIEW
    • 9.5.2. ASIA PACIFIC CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.5.3. ASIA PACIFIC CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.5.4. CHINA
    • 9.5.5. JAPAN
    • 9.5.6. INDIA
    • 9.5.7. REST OF ASIA PACIFIC
  • 9.6. LATIN AMERICA
    • 9.6.1. OVERVIEW
    • 9.6.2. LATIN AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.6.3. LATIN AMERICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.6.4. BRAZIL
    • 9.6.5. REST OF LATIN AMERICA
  • 9.7. MIDDLE EAST & AFRICA
    • 9.7.1. OVERVIEW
    • 9.7.2. MIDDLE EAST & AFRICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY MARKET SEGMENT
    • 9.7.3. MIDDLE EAST & AFRICA CELL THERAPY INSTRUMENT MARKET ESTIMATE BY COUNTRY
    • 9.7.4. MIDDLE EAST
    • 9.7.5. AFRICA

10 COMPETITIVE LANDSCAPE OF THE CELL THERAPY INSTRUMENT COMPANIES

  • 10.1. CELL THERAPY INSTRUMENT MARKET COMPETITION
  • 10.2. PARTNERSHIP/COLLABORATION/AGREEMENT
  • 10.3. MERGER AND ACQUISITIONS
  • 10.4. NEW PRODUCT LAUNCH
  • 10.5. OTHER DEVELOPMENTS

11 COMPANY PROFILES OF CELL THERAPY INSTRUMENT INDUSTRY

  • 11.1. COMPANY SHARE ANALYSIS
  • 11.2. MARKET CONCENTRATION RATE
  • 11.3. BD BIOSCIENCE
    • 11.3.1. COMPANY OVERVIEW:
    • 11.3.2. FINANCIALS:
    • 11.3.3. PRODUCTS:
    • 11.3.4. RECENT DEVELOPMENTS:
  • 11.1. DANAHER (BECKMAN COULTER, INC).
    • 11.1.1. COMPANY OVERVIEW:
    • 11.1.2. FINANCIALS:
    • 11.1.3. PRODUCTS:
    • 11.1.4. RECENT DEVELOPMENTS:
  • 11.1. GENERAL ELECTRIC
    • 11.1.1. COMPANY OVERVIEW:
    • 11.1.2. FINANCIALS:
    • 11.1.3. PRODUCTS:
    • 11.1.4. RECENT DEVELOPMENTS:
  • 11.2. LONZA
    • 11.2.1. COMPANY OVERVIEW:
    • 11.2.2. FINANCIALS:
    • 11.2.3. PRODUCTS:
    • 11.2.4. RECENT DEVELOPMENTS:
  • 11.3. MERCK KGAA
    • 11.3.1. COMPANY OVERVIEW:
    • 11.3.2. FINANCIALS:
    • 11.3.3. PRODUCTS:
    • 11.3.4. RECENT DEVELOPMENTS:
  • 11.1. MILTENYI BIOTEC
    • 11.1.1. COMPANY OVERVIEW:
    • 11.1.2. FINANCIALS:
    • 11.1.3. PRODUCTS:
    • 11.1.4. RECENT DEVELOPMENTS:
  • 11.2. SARTORIUS AG
    • 11.2.1. COMPANY OVERVIEW:
    • 11.2.2. FINANCIALS:
    • 11.2.3. PRODUCTS:
    • 11.2.4. RECENT DEVELOPMENTS:
  • 11.3. STEMCELL TECHNOLOGIES INC.
    • 11.3.1. COMPANY OVERVIEW:
    • 11.3.2. FINANCIALS:
    • 11.3.3. PRODUCTS:
    • 11.3.4. RECENT DEVELOPMENTS:
  • 11.4. TERUMO CORPORATION
    • 11.4.1. COMPANY OVERVIEW:
    • 11.4.2. FINANCIALS:
    • 11.4.3. PRODUCTS:
    • 11.4.4. RECENT DEVELOPMENTS:
  • 11.5. THERMO FISHER SCIENTIFIC INC.
    • 11.5.1. COMPANY OVERVIEW:
    • 11.5.2. FINANCIALS:
    • 11.5.3. PRODUCTS:
    • 11.5.4. RECENT DEVELOPMENTS:
Back to Top